用mRNA编码的纳米体向病毒复制复合体:抗病毒设计的新前沿
Jeremy Blavier1, Gennaro Esposito2, Jean-Claude Twizere1
1Laboratory of Viral Interactomes, Unit of Molecular Biology of Diseases, GIGA Institute, University of Liege, Liège, Belgium.
Drug discovery today
|November 16, 2025
概括
开发广泛的抗病毒药物对全球健康至关重要. 这项研究建议使用mRNA递送的纳米体来向病毒复制复合体,提供对新兴RNA病毒的快速治疗策略.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 新兴和重新出现的RNA病毒对全球健康构成重大威胁.
- 现有的广谱抗病毒药物在快速部署和细胞内传递方面面临挑战.
- 向保存的病毒复制-转录复合体 (RTCs) 是广泛的抗病毒开发的一个有前途的战略.
研究的目的:
- 提出和验证一个新的家族特定的抗病毒设计策略.
- 为了克服基于抗体的生物制剂的细胞内输送的局限性.
- 开发一个多功能平台,快速开发抗病毒,对抗RNA病毒.
主要方法:
- 使用纳米体向保存的病毒复制-转录复合体 (RTC).
- 使用mRNA疗法通过脂质纳米颗粒进行纳米体的细胞内传递.
- 使用SARS-CoV-2非结构蛋白9 (NSP9) 作为概念验证目标.
主要成果:
- 证明稳定非功能NSP9寡合体可以抑制病毒复制.
- 通过使用mRNA技术,成功地在细胞内输送了功能性纳米体.
- 验证了纳米体-mRNA疗法的破坏病毒RTC的潜力.
结论:
- 纳米体-mRNA技术平台为快速抗病毒开发提供了一种多功能方法.
- 这一策略有效地针对病毒RTC中的基本蛋白质-蛋白质相互作用.
- 这种方法显示出对抗一系列RNA病毒的希望,增强全球卫生准备.
关键词:
流行病的准备情况.这就是SARS-CoV-2病毒.这是一种抗病毒药物.冠状病毒冠状病毒的新冠病毒.在mRNA疗法中使用的mRNA疗法.纳米体是一种纳米体.复制转录复杂复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制复制相关概念视频
Viruses with RNA Genomes
774
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
774
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Retrovirus Life Cycles
49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K
RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K


